Abstract
The existence of intrinsic limitations of premature drug release and the association of toxicity with conventional and traditional cancer therapies encouraged researchers to develop nanotechnology-based medication. Overcoming the limitations of nanotherapy-based biodegradable carriers or vehicles plays an essential role in the field of medicine and healthcare due to minimal side effects, and more effective and safer drug therapy with more pharmacological response. Polycarbonates (PCs) showed assurance in achieving the stringent obligations placed on these delivery systems or vehicles. PC-based nanotechnology has synergistically fueled the advancement of drug delivery due to good biocompatibility, biodegradability, and stability. These features have enabled the development of numerous PC-based platforms for applications in drug delivery, injectable hydrogels, antimicrobials, and cancer therapy.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Polymeric Nanoparticles as a Promising Tool for Anti-cancer Therapeutics
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
